欧美最新另类人妖I国产成人av一区二区三区在线观看I九九热精品视频在线观看I国产精品日韩在线I激情av五月婷婷I日韩精品免费

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Aspergillus clavatus Ribosome biogenesis protein ytm1 (ytm1) CSB-YP373014AVC
CSB-EP373014AVC
CSB-BP373014AVC
CSB-MP373014AVC
CSB-EP373014AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Formation of crista junctions protein 1 (fcj1), partial CSB-YP373015AVC1
CSB-EP373015AVC1
CSB-BP373015AVC1
CSB-MP373015AVC1
CSB-EP373015AVC1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Elongation factor G, mitochondrial (mef1), partial CSB-YP373016AVC
CSB-EP373016AVC
CSB-BP373016AVC
CSB-MP373016AVC
CSB-EP373016AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Pre-mRNA-splicing ATP-dependent RNA helicase prp28 (prp28), partial CSB-YP373017AVC
CSB-EP373017AVC
CSB-BP373017AVC
CSB-MP373017AVC
CSB-EP373017AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Probable dipeptidyl peptidase 4 (dpp4), partial CSB-YP373018AVC
CSB-EP373018AVC
CSB-BP373018AVC
CSB-MP373018AVC
CSB-EP373018AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Kynureninase 2 (bna5-2) CSB-YP373019AVC
CSB-EP373019AVC
CSB-BP373019AVC
CSB-MP373019AVC
CSB-EP373019AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Transcriptional activator of proteases prtT (prtT), partial CSB-YP373020AVC
CSB-EP373020AVC
CSB-BP373020AVC
CSB-MP373020AVC
CSB-EP373020AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Alkaline protease 1 (alp1) CSB-YP373021AVC
CSB-EP373021AVC
CSB-BP373021AVC
CSB-MP373021AVC
CSB-EP373021AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus tRNA (guanine-N (7)-)-methyltransferase CSB-YP373022AVC
CSB-EP373022AVC
CSB-BP373022AVC
CSB-MP373022AVC
CSB-EP373022AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Glucose-repressible alcohol dehydrogenase transcriptional effector (ccr4), partial CSB-YP373023AVC
CSB-EP373023AVC
CSB-BP373023AVC
CSB-MP373023AVC
CSB-EP373023AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Methylthioribulose-1-phosphate dehydratase (mde1) CSB-YP373024AVC
CSB-EP373024AVC
CSB-BP373024AVC
CSB-MP373024AVC
CSB-EP373024AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Probable ubiquitin carboxyl-terminal hydrolase creB (creB), partial CSB-YP373025AVC
CSB-EP373025AVC
CSB-BP373025AVC
CSB-MP373025AVC
CSB-EP373025AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Golgi apparatus membrane protein tvp23 (tvp23), partial CSB-YP373026AVC1
CSB-EP373026AVC1
CSB-BP373026AVC1
CSB-MP373026AVC1
CSB-EP373026AVC1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Probable endopolygalacturonase I (pgaI) CSB-YP373027AVC
CSB-EP373027AVC
CSB-BP373027AVC
CSB-MP373027AVC
CSB-EP373027AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Histone H2B (htb1) CSB-YP373028AVC
CSB-EP373028AVC
CSB-BP373028AVC
CSB-MP373028AVC
CSB-EP373028AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus ATP-dependent RNA helicase dhh1 (dhh1), partial CSB-YP373029AVC
CSB-EP373029AVC
CSB-BP373029AVC
CSB-MP373029AVC
CSB-EP373029AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Ubiquinone biosynthesis protein coq4, mitochondrial (coq4) CSB-YP373030AVC
CSB-EP373030AVC
CSB-BP373030AVC
CSB-MP373030AVC
CSB-EP373030AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Lipoyl synthase, mitochondrial (ACLA_034510) CSB-YP373031AVC
CSB-EP373031AVC
CSB-BP373031AVC
CSB-MP373031AVC
CSB-EP373031AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Ribosome biogenesis protein nsa2 (nsa2) CSB-YP373032AVC
CSB-EP373032AVC
CSB-BP373032AVC
CSB-MP373032AVC
CSB-EP373032AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus clavatus Stress response protein nst1 (nst1), partial CSB-YP373033AVC
CSB-EP373033AVC
CSB-BP373033AVC
CSB-MP373033AVC
CSB-EP373033AVC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.practicalworld.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×